--;1,4-Dichlorobenzene-induced nephrotoxicity: similarity with unleaded gasoline-induced renal effects --;Comparison of the subacute nephrotoxicity of industrial solvents in the rat --;Nephrotoxic responses to multiple chemical exposure --;Dichlorovinyl cysteine accumulation and?-lyase activity in the developing mouse kidney --;Regioselective toxicity by dichlorovinylcysteine in rabbit renal cortical slices --;Use of LLC-PK1 monolayers as an in vitro model for nephrotoxicity --;Bioactivation, mechanism and cytotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine --;Role of biotransformation in acute N-(3,5-dichlorophenyl)-succinimide-induced nephrotoxicity --;Chloroform nephrotoxicity and renal uptake of calcium --;Renal pathology of orally administered L-triiodothyronine in the rat --;Lipid peroxidation as a possible cause of ochratoxin A toxicity --;Silicon in uremic rats --;Nephrotoxicity of experimental endotoxaemia in rats --;Studies on a physiologic model for the human renal Fanconi syndrome --;Chronic ureter cannula in pig --;Effects of glycerol-induced acute renal failure on renal phosphorus handling --;Renal haemodynamics and renin response during acute hypercapnea in dogs --;The isolated perfused rat kidney: filtering and non-filtering models in the assessment of altered renal vascular resistance in nephrotoxicity --;Endotoxin-hemoglobin induced nephropathy and haptoglobin administration --;Partially purified bovine atrial fraction on animal kidney, smooth muscle and sodium transport in toad skin --;Investigations on the nephrotoxic potential of recombinant human tumor necrosis factor --;Characterisation of human renal embryonic antigens by monoclonal antibodies --;Species differences in the immunocytochemical distribution of Tamm-Horsfall glycoprotein --;Immunocytochemical localization of glutathione peroxidase in uremic rat kidney --;Urine glutathione-S-transferase associated with nephrotoxic drugs --;Age-related changes in renal brush borders brush b.
Text of Note
Species differences in renal structure and function --;Applications to the assessment of nephrotoxicity in man --;Lead induced nephrotoxicity: kidney calcium as an indicator of tubular injury --;Predicting the kidney burden of toxic metals --;A prospective study of proteinuria in cadmium workers --;Red blood cell negative charges as an index of the glomerular polyanion in chronic cadmium poisoning --;Some considerations on critical concentration of cadmium for renal toxicity in rats --;Historical perspective on cadmium-induced nephrotoxicity --;Cadmium may predispose mice to immune complex-mediated renal injury: another possible mechanism for cadmium-induced nephrotoxicity --;Nephrotoxicity of cadmium in chickens --;Differential effects of cadmium and mercury on lysosomal enzymes in the kidney of Myxine glutinosa --;The effects of cadmium and adriamycin on the isolated perfused glomerulus of Myxine glutinosa (Cyclostomata) --;Protective effect of low concentrations of mercury against mercuric chloride-induced nephrotoxicity --;Induction of antinuclear antibodies by mercuric chloride in mice --;Analysis of unscheduled DNA synthesis and S-phase synthesis in F344 rat kidney after in vivo treatment with mercuric chloride --;In vitro and in vivo mercuric chloride-induced nephrotoxicity assessed by tubular enzymes release --;Prevention and reversal of mercuric chloride-induced increases in renal vascular resistance by captopril --;Regioselective acute tubular necrosis in renal cortical slices following mercuric chloride and potassium dichromate: localization and transport studies --;In-vivo bone lead measurements and renal effects --;Early indicators of lead nephropathy --;Nephrotoxicity of uranyl fluoride and reversibility of renal injury in the rat --;Low molecular weight proteins in the kidney of copper-loaded rats --;Gold nephropathy --;effect of gold on immune response to renal tubular basement membrane (TBM) antigen in mice --;Drug induced renal effects of cyclosporine, aminoglycoside antibiotics and lithium: extrapolation of animal data to man --;Lithium-induced distal nephron dilatation in young rabbits with associated encephalitazoan cuniculi related interstitial fibrosis --;Urinary phospholipids patterns after treatment with aminoglycoside antibiotics and cis-platinum --;Comparative uptake and lysosomal phospholipidosis induced by gentamicin components C1, C1a and C2 --;Uptake and subcellular distribution of poly-L-aspartic acid, a protectant against aminoglycoside-induced nephrotoxicity, in rat kidney cortex --;Aminoglycoside antibiotics inhibit the phophatidylinositol cascade in renal proximal tubular cells : possible role in toxicity --;Silymarin ameliorates gentamicin nephrotoxicity --;Possible role of the renin-angiotensin system in the development of gentamicin nephrotoxicity in the rat --;Effect of furosemide and verapamil on gentamicin nephrotoxicity --;Renal phospholipidosis in rats after gentamicin and pefloxacin coadministration at low doses --;Morphological and functional impairments of the developing rat kidney exposed to gentamicin in utero --;Morphological and functional effects in rat neonates of aminoglycosides given to the mother during gestation --;Gentamicin-stimulated increase in para-aminohippurate uptake in renal cortical slices and isolated proximal tubular cells --;Investigation of gentamicin nephrotoxicity using renal brush border membrane vesicles --;Time dependent nephrotoxicity of amikacin --;Effect of latamoxef [Moxalactam] on tobramycin binding to kidney brush border membranes in rats --;Amphotericin-B nephrotoxicity is decreased by intravenous flucytosine in the rat --;Apparent amoxapine nephrotoxicity: dependence on rhabdomyolysis and acidosis --;Mechanisms of cyclosporin A nephrotoxicity --;rat to man --;The effects of cyclosporin A on the urine excretion of specific proteins in humans --;Renal tubular function in experimental and clinical cyclosporin nephrotoxicity --;The effect of biliary cannulation or ligation on cyclosporin A (CsA) nephrotoxicity in the rat --;Cyclosporine A-induced lipid peroxidation in rat renal microsomes and effect on glucose uptake by renal brush border membrane vesicles --;Chronic renal tubular damage caused by cyclosporin A --;Effects of acute and chronic cyclosporine administration on glomerular haemodynamics in rats --;Intracellular localization of cyclosporin A in the rat kidney --;Distribution of platinum amongst the subcellular organelles of the rat kidney after oral administration of cisplatin --;Alpha-methylglucose uptake by isolated rat kidney proximal tubular cells as a parameter for cell integrity in vitro --;Lipid peroxidation as a mechanism of cisplatin-induced nephrotoxicity --;Renal toxicity of cis-dichlorodiammine platinum in rats --;Uptake of cisplatin (195mpt) into LLCPK1 cells in the presence of diethyldithiocarbamate, (DDTC) mercaptoethane-sulphate (MESNA) and amiloride --;The effect of amiloride on cisplatin induced nephrotoxicity and the renal uptake of cisplatin (195mpt) in male Wistar rats --;The response of the pig kidney to a combination of cisplatin and irradiation --;The effect of acetazolamide and furosemide on lithium clearance and cisplatin nephrotoxicity in the rat --;Sensitivity of in vitro ion accumulation, gluconeogenesis and other parameters as indicators of cisplatin-induced renal toxicity --;Assessment of nephrotoxicity by analysis of a randomised multi-centre comparative study regarding the previous extent of kidney damage --;Drug pharmacokinetics in renal failure --;influence of disease type --;Analgesic related renal injury in man --;Progression of renal failure in analgesic associated nephropathy --;The renal reponse of a nonhuman primate (baboon) to certain nonsteroidal anti-inflammatory drugs --;Morphological changes in the pig kidney associated with an acutely induced renal papillary necrosis --;Upper urothelial carcinoma, using N-butyl-N-(4-hydroxybutyl)-nitrosamine and an acute papillary necrosis --;High resolution microscopic changes in an acutely induced renal papillary necrosis: morphology and enzyme histo-chemistry --;Cannulation of the bile duct protects against para-aminophenol-induced nephrotoxicity in the Fischer 344 rat --;Effects of antidotes on the hepato- and nephro-toxicity of paracetamol in the rat --;Celiptium induced lipid peroxidation and toxicity in rat renal cortex --;Nephrotoxicity of ifosfamide in combination chemotherapy --;Risk evaluation of muzolimine and furosemide in experimental models of nephrotoxicity --;The role of oxidative stress in cephaloridine nephrotoxicity --;Studies on the mechanism of radiological contrast media induced renal failure --;Radiocontrast nephrotoxicity in diabetes: clinical considerations and studies in the diabetic rat --;Renal microcirculation during urographic contrast media administration --;Hypertonic radiocontrast medium and the kidney: effects on renal function in the euvalaemic and in the dehydrated dogs --;Renal effects of ionic and nonionic contrast media: comparison between diatrizoate meglumine and Iopamidol --;Renal proton nuclear magnetic resonance in gentamicin, cyclosporin A and cisplatinum, acute renal failure in rats --;31Phosphorus NMR studies of mercuric chloride nephrotoxicity in the in vitro perfused rat kidney --;Application of 1H NMR urinalysis to the examination of nephrotoxic lesions induced by mercuric chloride, hexachloro-1, 3-butadiene, and propyleneimine --;Pathogenesis of protein droplet nephropathy and its relationship to renal carcinogenesis in the male rat --;Light hydrocarbon-induced nephrotoxicity: the interaction of 2,2,4-trimethylpentane with alpha-2u-globulin in the male rat kidney --;Male rat specific alpha-2u-globulin nephropathy and renal tumorigenesis --;Nephrotoxicity and studies on the reabsorption and disposal of alpha-2u-globulin --;Induction of hyaline droplet accumulation in renal cortex of male rats by aromatic compounds
SUMMARY OR ABSTRACT
Text of Note
There has been a growing awareness that nephrotoxicity represents a key factor in human nephropathies, where, irrespective of the causative agent, only a few clinical end-effects are diagnosed.